PTX
Click for more information
2.50% 3.9¢ prescient therapeutics limited

Ann: Investor Presentation - October 2017, page-6

  1. psych101
    1,656 Posts.
    lightbulb Created with Sketch. 198
    clock Created with Sketch.
    09/10/17
    15:00
    Post #: 27764847
    •As cytarabine is the current standard of care in AML, this suggests that PTX-200 may potentiate the standard of care, and have significant clinical relevance in the relapse/refractory setting (presentation p. 33)
    Missed this last presentation....,
    Primary standard of care potential, now that’s something to really look forward to.
    PTX Price at posting: 7.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢ 		Change
-0.001(2.50%) 		Mkt cap ! $31.40M
Open High Low Value Volume
4.0¢ 4.0¢ 3.8¢ $23.03K 590.2K

Buyers (Bids)

No. Vol. Price($)
2 25254 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 249836 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.